sb 203580 has been researched along with ha 1004 in 2 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (ha 1004) | Trials (ha 1004) | Recent Studies (post-2010) (ha 1004) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 234 | 0 | 6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
Sharp, PA; Tang, H | 1 |
2 other study(ies) available for sb 203580 and ha 1004
Article | Year |
---|---|
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |
Transcriptional regulation of the murine 3' IgH enhancer by OCT-2.
Topics: 3' Untranslated Regions; Alleles; Animals; B-Lymphocytes; Cyclic AMP-Dependent Protein Kinases; DNA; DNA-Binding Proteins; Enhancer Elements, Genetic; Enzyme Inhibitors; Gene Expression Regulation; Genistein; Imidazoles; Immunoglobulin Heavy Chains; Isoquinolines; Lipopolysaccharides; Lymphocyte Activation; Mice; Mice, Knockout; Mutagenesis, Site-Directed; Octamer Transcription Factor-2; Phosphorylation; Protein Binding; Protein Kinase C; Protein Processing, Post-Translational; Protein Structure, Tertiary; Pyridines; Recombinant Fusion Proteins; Staurosporine; Structure-Activity Relationship; Sulfonamides; Trans-Activators; Transcription Factors; Transcriptional Activation; Transfection | 1999 |